These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 24415157

  • 21. Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver disease score and renal function predict outcome.
    Voigtländer T, Negm AA, Schneider AS, Strassburg CP, Manns MP, Wedemeyer J, Lankisch TO.
    Endoscopy; 2012 Nov; 44(11):1055-8. PubMed ID: 23108773
    [Abstract] [Full Text] [Related]

  • 22. [Secondary sclerosing cholangitis in critically ill patients].
    Peña-Pérez CA, Díaz Ponce-Medrano JA.
    Cir Cir; 2018 Nov; 86(1):56-62. PubMed ID: 29681633
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?
    Bartoli A, Cursaro C, Seferi H, Andreone P.
    Hepat Med; 2023 Nov; 15():93-112. PubMed ID: 37547355
    [Abstract] [Full Text] [Related]

  • 26. Sclerosing cholangitis following severe trauma: description of a remarkable disease entity with emphasis on possible pathophysiologic mechanisms.
    Benninger J, Grobholz R, Oeztuerk Y, Antoni CH, Hahn EG, Singer MV, Strauss R.
    World J Gastroenterol; 2005 Jul 21; 11(27):4199-205. PubMed ID: 16015689
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients.
    Jüngst C, Stadlbauer V, Reichert MC, Zimmer V, Weber SN, Ofner-Ziegenfuß L, Voigtländer T, Spindelböck W, Fickert P, Kirchner GI, Lammert F, Lankisch TO, Krawczyk M.
    Sci Rep; 2017 Aug 01; 7(1):7026. PubMed ID: 28765628
    [Abstract] [Full Text] [Related]

  • 29. Sclerosing cholangitis and liver cirrhosis after extrabiliary infections: report on three cases.
    Scheppach W, Druge G, Wittenberg G, Mueller JG, Gassel AM, Gassel HJ, Richter F.
    Crit Care Med; 2001 Feb 01; 29(2):438-41. PubMed ID: 11246328
    [Abstract] [Full Text] [Related]

  • 30. BISCIT: Biliary interventions in critically ill patients with secondary sclerosing cholangitis-a study protocol for a multicenter, randomized, controlled parallel group trial.
    Stahl K, Klein F, Voigtländer T, Großhennig A, Book T, Müller T, Wree A, Kuellmer A, Weigt J, Dechene A, Wedi E, Kandulski A, Lange CM, Holzwart D, von Witzendorff D, Ringe KI, Wedemeyer H, Heidrich B, BISCIT Study group.
    Trials; 2023 Mar 31; 24(1):247. PubMed ID: 37004078
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Sclerosing cholangitis epidemiology and etiology.
    Lazaridis KN.
    J Gastrointest Surg; 2008 Mar 31; 12(3):417-9. PubMed ID: 17957439
    [Abstract] [Full Text] [Related]

  • 37. Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity.
    Martins P, Verdelho Machado M.
    GE Port J Gastroenterol; 2020 Feb 31; 27(2):103-114. PubMed ID: 32266307
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.